Cyclosporine in patients with severe steroid refractory ulcerative colitis in the era of infliximab. Review article.

References

• Travis SP, Farrant JM, Rickets C, Nolan DJ, Mortensen NM, Kettlewell MG, Predicting outcome in severe ulcerative colitis. Gut 1996;38:905–10.
   PubMed Web of Science ®Google Scholar
• Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut 1963;4:299–315.
   PubMed Web of Science ®Google Scholar
• Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955;2:1041–8.
   PubMed Web of Science ®Google Scholar
• Truelove SC, Jewell DP. Intensive intravenous regimen for severe attacks of ulcerative colitis. Lancet 1974;I:1067–70.
   Google Scholar
• Truelove SC, Willoughby CP, Lee EG, Kettlewell MGW. Further experience in the treatment of the severe attacks of ulcerative colitis. Lancet 1978;ii:1086–8.
   Google Scholar
• Jarnerot G, Rolny P, Sandberg-Gerzén H. Intensive intravenous treatment of ulcerative colitis. Gastroenterology 1985;89:10.
   Web of Science ®Google Scholar
• Hart AL, Ng SC. Review article: the optimal management of acute ulcerative colitis. Aliment Pharmacol Ther 2010;32:615–27.
   PubMed Web of Science ®Google Scholar
• Turner D, Walsh CM, Steinhart AH, Griffiths AM. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta regression. Clin Gastroenterol Hepatol 2007;5:103–10.
   PubMed Web of Science ®Google Scholar
• Tysk C, Almer S, Andersson M, Befrits R, Hertevig E, Kilander A, Lindgren S Handläggning av akut svårt skov av ulcerös kolit. Nationella riktlinjer. Gastrokuriren 2008;3:35–6.
   Google Scholar
• Järnerot G, Hertevig E, Friis-Liby I, Blomquist L, Karlén P. Grännö Ch, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled trial. Gastroenterology 2005;128:1805–11.
   PubMed Web of Science ®Google Scholar
• Gustavsson A, Järnerot G, Hertevik E, Friis-Liby I, Blomquist L, Karlén P, Clinical trial: colectomy after rescue therapy in ulcerative colitis – a 3-year follow up of the Swedish-Danish controlled infliximab study. Aliment Pharmacol Ther 2010;32:984–9.
   PubMed Web of Science ®Google Scholar
• Wilhelm SM, Mc Kenney KA, Rivait KN, Kale-Pradhan PB. A review of infliximab use in ulcerative colitis. Clin Ther 2008;30:223–30.
   PubMed Web of Science ®Google Scholar
• Hart AL, Ng SC. Review article: the optimal medical management of acute severe ulcerative colitis. Aliment Pharmacol Ther 2010;32:615–27.
   PubMed Web of Science ®Google Scholar
• Fabro M, Szabo H, Terrosu G, Avellini C, Tabuso M, Fiorino G, Acute severe colitis: infliximab and/or cyclosporine? Curr Drug Targets 2011;12:1448–53.
   PubMed Web of Science ®Google Scholar
• Brynskov J. Cyclosporine for inflammatory bowel disease: mechanism and possible actions. Scand J Gastroenterol 1993;28:849–57.
   PubMed Web of Science ®Google Scholar
• Durai D, Hawthorne AB. Review article: how and when to use cyclosporine in ulcerative colitis. Aliment Pharmacol Ther 2005;22:907–16.
   PubMed Web of Science ®Google Scholar
• Arts J, D´Haens G, Zeegers M, Van Assche G, Hiele M, D´Hoore A, Long-term outcome of treatment with intravenous cyclosporine in patients with severe ulcerative colitis. Inflamm Bowel Dis 2004;10:73–8.
   PubMed Web of Science ®Google Scholar
• Filipi J, Allen PB, Hébuterne X, Peyrin-Biroulet L. Does anti TNF therapy reduce the requirement for surgery in ulcerative colitis? Curr Drug Targets 2011;12:1440–4.
   PubMed Web of Science ®Google Scholar
• Rolny P, Sadik R. Longer term outcome of steroid refractory ulcerative colitis without subsequent oral cyclosporine therapy. Int J Colorectal Dis 2002;17:67–9.
   PubMed Web of Science ®Google Scholar
• Holme Ö, Thiis-Evensen E, Vatn MH. Treatment of fulminant ulcerative colitis with cyclosporine A. Scand J Gastroenterol 2009;44:1310–14.
   PubMed Web of Science ®Google Scholar
• Campbell S, Travis S, Jewell D. Cyclosporine in acute ulcerative colitis: a long term experience. Eur J Gastroenterol Hepatol 2005;17:7.
   Web of Science ®Google Scholar
• Moskovitz DN, Van Assche G, Maenhout B, Arts J, Ferrante M, Vermeire S, Incidence of colectomy during long-term follow-up after cyclosporin-induced remission of severe ulcerative colitis. Clin Gastroenterol Hepatol 2006;4:760–5.
   PubMed Web of Science ®Google Scholar
• Sternthal MB, Murphy SJ, George J, Kornbluth A, Lichtiger S, Present DH. Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease. Am J Gastroenterol 2008;103:937–43.
   PubMed Web of Science ®Google Scholar
• Doherty GA, Cheifetz AS. Management of acute severe ulcerative colitis. Expert Rev Gastroenterol Hepatol 2009;3:325–7.
   PubMedGoogle Scholar
• Burger D, Travis S. Conventional medical management of inflammatory bowel disease. Gastroenterology 2001;140:1827–37.
   Google Scholar
• Ng SC, Kamm MA. Therapeutic strategies for the management of ulcerative colitis. Inflamm Bowel Dis 2009;15:935–50.
   PubMed Web of Science ®Google Scholar
• Van Assche G, Vermeire S, Rutgeerts P. Management of acute severe ulcerative colitis. Gut 2011;60:130–3.
   PubMed Web of Science ®Google Scholar
• Kornbluth A, Sachar D; and the practice parameters committee of the American college of gastroenterology. Ulcerative colitis practice guidelines in adults: American college of gastroenterology, practice parameters committee. Am J Gastroenterol 2010;105:501–23.
   PubMed Web of Science ®Google Scholar
• Travis SPL, Stange EF, Léman M, Oresland T, Bemelman WA, Chowers Y, European evidence based consensus on the management of the ulcerative colitis: current management. JCC 2008;2:24–62.
   Google Scholar
• Talley NJ, Abreu MT, Achkar J-P, Bernstein CN, Dubinsky MC, Hanauer SB, An evidence-based systematic review on medical therapies for inflammatory bowel disease. Am J Gastroenterol 2011;106:S2–S52.
   PubMed Web of Science ®Google Scholar
• Bitton A, Buie D, Enns R, Feagan B, Jones JL, Marshall JL, on behalf of the Canadian Association of Gastroenterology severe ulcerative colitis consensus group. Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements. Am J Gastroenterol 2012;107:179–94.
   PubMed Web of Science ®Google Scholar
• Meier J, Sturm A. Current treatment of ulcerative colitis. WJG 2011;17:3204–12.
   PubMed Web of Science ®Google Scholar
• Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, Guidelines for the management of inflammatory bowel disease in adults. Gut 2011;60:571–607.
   PubMed Web of Science ®Google Scholar
• Sanborn WJ. A critical review of cyclosporine therapy in inflammatory bowel disease. Inflamm bowel Dis 1995;1:48–63.
   Google Scholar
• Van Assche G, D´Haens G, Noman M, Vermeire S, Hiele F, Asnong K, Randomized, double blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis. Gastroenterology 2003;125:1025–31.
   PubMed Web of Science ®Google Scholar
• Rayner CK, Mc Cormack G, Emmanuel AV, Kamm MA. Long-term results of low dose intravenous cyclosporine for acute severe ulcerative colitis. Aliment Pharmacol Ther 2003;18:303–8.
   PubMed Web of Science ®Google Scholar
• Actis GC, Ottobrelli A, Pera A, Barletti C, Ponti V, Pinna-Pintor M, Continuouly infused cyclosporine at low dose is sufficient to avoid emergency colectomy in acute attacks of ulcerative colitis without need for high dose steroids. J Clin Gastroenterol 1993;17:10–11.
   PubMed Web of Science ®Google Scholar
• Murphy SJ, Kornbluth A, Present DH. Cyclosporine in acute colitis. Am J Gatroenterol 2008;103:2654–5.
   PubMed Web of Science ®Google Scholar
• Bojic D, Radojicic Z, Nedeljkovic-Protic M, Jewell DP, Travis SPL. Long-term outcome after admission for acute severe ulcerative colitis I Oxford: the 1992–1993 cohort. Inflamm Bowel Dis 2009;15:823–8.
   PubMed Web of Science ®Google Scholar
• Fernandez-Banares F, Bertran X, Esteve-Comas M, Cabré E, Menacho M, Humbert P, Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid refractory severe ulcerative colitis. Am J Gastroenterol 1996;12:2498–9.
   Google Scholar
• Domenéc E, Garcia-Plamella E, Bernal I, Rosinach M, Cabré E, Fluvià L, Azathioprine without oral cyclosporine in the long-term maintenance of remission induced by intravenous cyclosporine in severe steroid refractory ulcerative colitis. Aliment Pharmacol Ther 2002;16:2061–5.
   PubMed Web of Science ®Google Scholar
• Actis GC, Fadda M, David E, Sapiro A. Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long term retrospective cohort study BMC. Gastroenterology 2007;7:13.
   PubMed Web of Science ®Google Scholar
• Chefetz AS, Stern J, Garud S, Goldstein E, Malter L, Moss AC, Cyclosporine is safe and effective in patients with severe ulcerative colitis. J Clin Gastroenterol 2011;45:107–1112.
   PubMed Web of Science ®Google Scholar
• Mc Dermott RP, Green JA, Ashley CC. What is the optimal therapy for severe ulcerative colitis? Inflamm Bowel Dis 2008;14–S228–31.
   Web of Science ®Google Scholar
• Sharkey L, Bredin F, Nightingale A, Parkes M. The use of cyclosporine A in acute steroid refractory ulcerative colitis: long term outcomes. J Crohns Colitis 2011;5:91–4.
   PubMed Web of Science ®Google Scholar
• Weber A, Fein F, Koch S, Dupont-Gossart AC, Mantion G, Heyd B, Treatment of ulcerative colitis refractory to steroid therapy by oral micro emulsion cyclosporine (Neoral). Inflamm Bowel Dis 2006;12:1131–5.
   PubMed Web of Science ®Google Scholar
• Kumar P, Rowbotan D. Cyclosporine A as rescue therapy for steroid refractory acute severe colitis: oral administration is as effective as intravenous. J Crohns Colitis 2012;6:S141.
   Google Scholar
• Walch A, Meshkat M, Vogelsang H, Novacek G, Dejacoc C, Angelberger S, Long term outcome in patients with ulcerative colitis treated with intravenous cyclosporine A is determined by previous exposure to azathioprine. J Crohns Colitis 2010;4:398–404.
   PubMed Web of Science ®Google Scholar
• Sjöberg M, Walch A, Meshkat M, Gustavsson A, Järnerot G, Volgesang H, Infliximab or cyclosporine as rescue therapy in hospitalized patients with steroid refractory ulcerative colitis: a retrospective observational study. Inflamm Bowel Dis 2011;18:212–18.
   PubMed Web of Science ®Google Scholar
• Dean KE, Hikaka J, Huakau JT, Walmsley RS. Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis. J Gastroenterol Hepatol 2012;27:487–92.
   PubMed Web of Science ®Google Scholar
• Branche J, Allez M, Bouhnik Y, Filippi J, Cyclosporine versus infliximab in acute severe colitis. J Crohns Colitis 2011;5:S8.
   Google Scholar
• Bossa F, Caruso N, Accadia A, Merta AM, Ippolito GA, Niro GA, Oral cyclosporine versus infliximab in patients with severe ulcerative colitis refractory to iv steroids. Preliminary data of a controlled, randomized study. J Crohns Colitis 2009;3:S61.
   Google Scholar
• Jakobovits SL, Jewell DP, Travis SPL. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006. Aliment Pharmacol Ther 2007;25:1055–60.
   PubMed Web of Science ®Google Scholar
• Lees CW, Heys D, Ho GT, Noble CL, Shand AG, Mowat C, on behalf of Scottish society of gastroenterology infliximab group. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis. Aliment Pharmacol Ther 2007;26:411–19.
   PubMed Web of Science ®Google Scholar
• Hyde GM, Jewell DP, Kettlewell MGW, Mortensen C. Cyclosporin for severe ulcerative colitis does not increase the rate of postoperative complications. Dis Colon Rectum 2001;44:1436–40.
   PubMed Web of Science ®Google Scholar
• Norgård BM, Nielsen J, Qvist N, Gradel KO, de Muckadel OBS, Kjeldsen J. Preoperative use of anti-TNF agents and the risk of postoperative complications in patients with ulcerative colitis-a nationwide cohort studies. Aliment Pharmacol Ther 2012;35:1301–9.
   PubMedGoogle Scholar
• Mor IJ, Vogel JD, da Luz Moreira A, Shen B, hammel J, Remzi FH. Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis Colon Rectum 2008;51:1202–7.
   PubMed Web of Science ®Google Scholar
• Yang Z, Wu Q, Wu K, Fan D. Meta-analysis: pre-operative infliximab treatment and short term post-operative complications in patients with ulcerative colitis. Aliment Pharmacol Ther 2010;31:486–92.
   PubMed Web of Science ®Google Scholar
• Nguyen GC, Prather CM. Is keeping the colon the ultimate marker of success in ulcerative colitis? Gastroenterology 2009;137:1204–6.
   PubMed Web of Science ®Google Scholar
• Teisner AS, Ainsworth MA, Brynskov J. Long term effects and colectomy rates in ulcerative colitis patients treated with infliximab: a Danish single centre experience. Scand J Gastroenterol 2010;45:1457–6.
   PubMed Web of Science ®Google Scholar
• Williet N, Pillot C, Oussalah A, Billioud V, Chevaux J-B, Bressler L, Incidence of and impact of medications on colectomy in newly diagnosed ulcerative colitis in the era of biologics. Inflamm Bowel Dis 2011; Epub ahead of print.
   Web of Science ®Google Scholar
• Ehteshami-Afshar S, Nikfar S, Rezaie A, Abdollahi M. A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease. Arch Med Sci 2011;7:1000–12.
   PubMed Web of Science ®Google Scholar
• Aratari A, Papi C, Clemente V, Moretti A, Luchetti R, Koch M, Colectomy rates in acute severe ulcerative colitis in the infliximab era. Dig Liver Dis 2008;40:821–6.
   PubMedGoogle Scholar
• Chetfetz AS, Rosenberg L. Infliximab decreases colectomy rates in moderate to severe ulcerative colitis: big news or big deal? Inflamm Bowel Dis 2011;17:1626–8.
   PubMed Web of Science ®Google Scholar
• D´Haens G, Lemmens L, Geboes K, Vandeputte L, Van Acker F, Mortelmans L, Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis. Gastroenterology 2001;120:1323–9.
   PubMed Web of Science ®Google Scholar
• Ochsenkühn T, Sackman M, Göke B. Infliximab for acute, not steroid-refractory ulcerative colitis: a randomized pilot study. Eur J Gastroenterol Hepatol 2004;16:1167–71.
   PubMed Web of Science ®Google Scholar
• Habal FM, Huang VW. Review article: a decision – making algorithm for the management of pregnancy in the inflammatory bowel disease patient. Aliment Pharmacol Ther 2012;35:501–15.
   PubMed Web of Science ®Google Scholar
• Branche J, Corot A, Bourreile A, Coffin B, de Vos M, de Saussure P, Cyclosporine treatment of steroid refractory ulcerative colitis during pregnancy. Inflamm Bowel Dis 2009;15:1044–8.
   PubMed Web of Science ®Google Scholar
• Arnott ID, Leiper K, Down C. Otcome of acute severe ulcerative colitis: data from the UK National IBD Audit. Gastroenterology 2010;138:S–106.
   Web of Science ®Google Scholar
• Stenner JMC, White P, Gould SR, Lim AG. Audit on the management of severe ulcerative colitis in a DGH. Gut 2001;48:A 87.
   PubMed Web of Science ®Google Scholar
• De Silva S, Ma C, Proulx M-C, Crespin M, Kaplan BS, Hubbard J, Postoperative complications and mortality following colectomy for ulcerative colitis. Clin gastroenterol Hepatol 2011;9:972–80.
   PubMed Web of Science ®Google Scholar
• Becker JM, Stucchi AF. Treatment of choice for acute severe steroid refractory ulcerative colitis is colectomy. Inflamm Bowel Dis 2009;15:150–1.
   PubMed Web of Science ®Google Scholar
• Öresland T. Review article: colon saving medical therapy vs. colectomy – the case for colectomy. Aliment Pharmacol Ther 2006;24:74–9.
   PubMed Web of Science ®Google Scholar
• Roberts SE, Williams JG, Yeates D, Goldacre M. Mortality in patients with and without colectomy admitted to hospital for ulcerative colitis and Crohn´s disease: record linkage studies. BMJ 2007;335:1033.
   PubMedGoogle Scholar
• Arseneau KO, Sultan S, Provenzale DT, Onken J, Bickston SJ, Foley E, Do patient preferences influence decisions on treatment for patients with steroid-refractory ulcerative colitis? Clin Gastroenterol Hepatol 2006;4:1135–42.
   PubMed Web of Science ®Google Scholar
• Kamm MA. Early surgical intervention in ulcerative colitis. Gut 2004;53:308–9.
   PubMedGoogle Scholar
• Öresland T, Moum B. Kirurgi, inflammatorisk tarm sykdom og biologisk behandling. Tidskr Nor Legeforen 2009;129:2389–90.
   PubMedGoogle Scholar